Praxis Precision Medicines (PRAX) Return on Sales (2023 - 2025)
Praxis Precision Medicines' (PRAX) quarterly Return on Sales came in at 0.7% in Q3 2025, up 156.0% year-on-year from 0.27% in Q3 2024, and down 7.92% quarter-over-quarter from 0.65% in Q2 2025.
Praxis Precision Medicines (PRAX) Return on Sales (2023 - 2025) Analysis & Trends
Praxis Precision Medicines' Return on Sales history runs 3 years deep, the most recent figure standing at 0.7% for Q3 2025.
- On a quarterly basis, Return on Sales rose 156.0% year-over-year to 0.7% in Q3 2025; TTM through Sep 2025 was 0.7%, a 162.0% increase from a year earlier, with the FY2024 full-year figure at 0.49%, up 76.0% from the prior year.
- Return on Sales eased to 0.7% in Q3 2025 per PRAX's latest filing, from 0.65% in the prior quarter.
- Across five years, Return on Sales topped out at 0.38% in Q4 2024 and bottomed at 4.04% in Q4 2023.
- The 3-year median for Return on Sales is 0.65% (2025), against an average of 1.14%.
- Biggest YoY gain for Return on Sales was 367 bps in 2024; the steepest drop was 171 bps in 2024.
- Year by year, Return on Sales stood at 4.04% in 2023, then jumped by 91 bps to 0.38% in 2024, then sank by 85 bps to 0.7% in 2025.
- Per Business Quant, the three latest PRAX Return on Sales figures stand at 0.7% (Q3 2025), 0.65% (Q2 2025), and 0.57% (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Praxis Precision Medicines | 8.98 Bn | 8.20 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.70% |
| Jun 30, 2025 | -0.65% |
| Mar 31, 2025 | -0.57% |
| Dec 31, 2024 | -0.38% |
| Sep 30, 2024 | -2.26% |
| Jun 30, 2024 | -1.10% |
| Mar 31, 2024 | -1.30% |
| Dec 31, 2023 | -4.04% |
| Sep 30, 2023 | -0.55% |
| Jun 30, 2023 | -0.45% |
| Mar 31, 2023 | -0.56% |